A Study Examining the Use of Vaginal Nifedipine With Pelvic Floor Physical Therapy for Levator Myalgia and Pelvic Pain

Inclusion Criteria: * Subject has levator myalgia upon appropriate pelvic exam that reproduces HPI pain * Subject has symptoms such as voiding dysfunction, dyspareunia, vaginismus, or obstructed defecation * Subject is willing and able to give written consent for the study * Subject is willing to undergo treatment with pelvic physical therapy \& vaginal nifedipine * Subject is able to speak, read, and write in English * Subject is at least 18 years of age Exclusion Criteria: * Subject has previously diagnosed interstitial cystitis * Subject has an active case of symptomatic HSV, syphilis, or shingles * Subject has a history of uncontrolled hypertension * Subject is already taking a calcium channel blocker * Subject has a history of MI, CHF, or arrhythmia * Subject has a history of neurologic disease * Subject has a history of congenital or progressive musculoskeletal disease * Subject has a history of bladder or pelvic cancer and/or pelvic radiation * Subject is planning to be or currently pregnant * Subject has known allergy or adverse reaction to nifedipine * Subject has known allergy or adverse reaction to lanolin, mineral oil, petrolatum * Subject is undergoing pharmacologic treatment specific to pelvic pain * Subject is taking oral beta adrenergic antagonist medication * Subject has an active pelvic or vaginal infection * Subjects with hypotension on screening physical examination (i.e. confirmed SBP\<90 mmHg or DBP\<60 mmHg).